(Q30047193)

25 May 2017

0 references

0 references

1 reference

Ralitza Gueorguieva

8

0 references

author name string

Deepak Cyril D'Souza

1

1 reference

25 May 2017

Edward Perry

2

1 reference

25 May 2017

Lisa MacDougall

3

1 reference

25 May 2017

Yola Ammerman

4

1 reference

25 May 2017

Thomas Cooper

5

1 reference

25 May 2017

Yu-te Wu

6

1 reference

25 May 2017

Gabriel Braley

7

1 reference

25 May 2017

John Harrison Krystal

9

1 reference

25 May 2017

language of work or name

English

0 references

publication date

2 June 2004

1 reference

25 May 2017

published in

Neuropsychopharmacology

1 reference

25 May 2017

volume

29

1 reference

25 May 2017

page(s)

1558-1572

1 reference

25 May 2017

issue

8

1 reference

Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabis and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Amphetamine psychosis: behavioral and biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Levels of processing and acute effects of marijuana on memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Is verbal recognition memory really different in Huntington's and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Long-term retention of implicit learning in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Reinforcing and subjective effects of oral Δ9-THC and smoked marijuana in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

The neurobiology and evolution of cannabinoid signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Acute and residual effects of marijuana in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of acute smoked marijuana on complex cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Comparative effects of alcohol and marijuana on mood, memory, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Psychiatric effects of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Endocannabinoids in cognition and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Provocative tests with psychostimulant drugs in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Divided attention performance in cannabis users and non-users following alcohol and cannabis separately and in combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Marijuana and memory impairment: effect on free recall and recognition memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effect of repeated administration of delta 9-tetrahydrocannabinol on delayed matching-to-sample performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid-induced Fos expression within A10 dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Some features of Cannabis plants grown in the United Kingdom from seeds of known origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

The psychoactive ingredient of marijuana induces behavioural sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabis is more than simply delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of long-term cannabis use on selective attention: An event-related potential study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

The Metabolism of Δ9-Tetrahydrocannabinol and Related Cannabinoids in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

An integrated view of pathophysiological models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Addiction Research Center Inventory (ARCI): development of a general drug estimation scale

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Cannabis and Cognitive Functioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Abnormal neural synchrony in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

The DSM-III-R field trial of disruptive behavior disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Effects of cannabidiol in animal models predictive of antipsychotic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300496

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300496

2 references

25 May 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

2624144

1001692764

0 references

2624144

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference